• Empowering Postmenopausal Sexual Health: FDA Expands Approval of Addyi for Hypoactive Sexual Desire Disorder

    December 19, 2025

    A long-awaited FDA decision now allows medical spa professionals to prescribe Addyi (flibanserin) for postmenopausal women under age 65 experiencing hypoactive sexual [...]

  • Radiofrequency and Non-RF Microneedling Safety: What Patients Should Know

    December 4, 2025

    With Molly Muecke, RN, MSN, NP-CMicroneedling is a popular aesthetic treatment offered in 79% of med spas (2024 Medical Spa State of [...]

  • New Guidelines on the Use of GLP-1 Medication for Managing Weight

    December 3, 2025

    GLP-1 medication has become the go-to treatment for people struggling with losing weight. As peptides are primarily prescribed for the management of [...]

  • Q&A: Merz Aesthetics’ Patrick Urban Discusses New FDA Clearance Areas for Ultherapy PRIME

    December 2, 2025

    On November 5, 2025, Merz Aesthetics announced that Ultherapy PRIME® gained U.S. Food and Drug Administration (FDA) clearance to improve the appearance [...]

  • When Menopause Meets Misinformation: How to Be the Expert Your Patients Trust

    November 21, 2025

    By Belmar Pharma SolutionsWhen it comes to menopause, a once-taboo topic, the tide has finally changed. Women now have access to an [...]

  • Rooted in Partnership: Exhibitors Show Up and Show Out at Medical Spa Show

    November 18, 2025

    Want to stay ahead of the curve in medical aesthetics? The Medical Spa Show 2026 (MSS26) is your ultimate opportunity to discover groundbreaking technologies, explore regenerative wellness trends, and find innovative business solutions.

  • FDA Removes Black Box Warning from Hormone Replacement Treatment

    November 14, 2025

    Hormone replacement therapy is a key component of regenerative medicine. It is particularly useful in the management of menopausal changes. The Food [...]

  • FDA Issues RF Microneedling Safety Alert: What It Means for Medical Spa Professionals

    November 6, 2025

    The FDA’s recent safety communication regarding radiofrequency (RF) microneedling devices is a critical reminder: Aesthetic treatments involving energy-based devices are medical procedures [...]

  • New Indications: Merz Aesthetics’ Ultherapy PRIME Gains FDA Clearance for Abdomen, Anterior and Posterior Arms

    November 5, 2025

    Ultherapy PRIME is now the only FDA-cleared solution with real-time visualization to treat the face, neck, décolleté and the body.1  Ultherapy PRIME [...]

  • Galderma Receives U.S. FDA Approval for Restylane Lyft for the Enhancement of the Chin Profile

    November 5, 2025

    Galderma, the world’s largest independent global dermatology company, today announced that the U.S. Food and Drug Administration (FDA) has approved Restylane Lyft [...]

  • Rooted in Purpose: Early Bird Registration Now Open for Medical Spa Show 2026

    November 4, 2025

    Something remarkable happens every year in Las Vegas when the medical spa community arrives for Medical Spa Show. This April 9–12, 2026, [...]

  • Mayo Clinic Shares Longevity Framework for Skin Aging: “Skinspan”

    October 30, 2025

    As the global population ages, so does our skin. A new study from Mayo Clinic offers a groundbreaking framework to help extend [...]